Severe symptoms may require immediate and urgent attention
For the weekly injection (2.4 mg), the STEP 1 trial showed sustained, clinically relevant weight reduction versus placebo in adults with overweight or obesity, as published in PubMed and in The New England Journal of Medicine
GLP-1 and Microbiome Repair for Appetite Control and Long-Term Metabolism GLP-1 & Microbiome Knowledge Hub Quick Answer GLP-1 is a metabolic hormone regulated indirectly by the gut microbiome
The potential for pharmacodynamic interactions between retatrutide and antihypertensive medicines is a clinically relevant consideration, particularly given that hypertension is highly prevalent among individuals with obesity the primary population likely to be treated with this agent
Integrative Medicine: A Clinicians Journal , 15 (2), 6
How do I maximize my results on Semaglutide